Stay updated on Pembrolizumab in Neuroendocrine Tumors Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Neuroendocrine Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Neuroendocrine Tumors Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A site-wide notice announces that NIH content may use “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI) during a transition.
    Difference
    1%
    Check dated 2026-10-24T17:07:28.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T16:50:25.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The site revision identifier in the footer changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-10T17:17:19.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the usual content with an access-block message and standard site chrome.
    Difference
    17%
    Check dated 2026-09-19T18:30:46.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.5 to v3.6.6. This indicates a small backend/template update to the study details page and does not modify the displayed content.
    Difference
    0.1%
    Check dated 2026-08-29T20:04:28.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    Revision: v3.6.5 was added, replacing the previous v3.6.4 on the page. This signals a minor platform update without changing the study's content or data presented.
    Difference
    0.1%
    Check dated 2026-08-08T20:13:14.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Neuroendocrine Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Neuroendocrine Tumors Clinical Trial page.